MADRID, Oct. 16, 2019 -- Pharmactive Biotech Products, S.L., launches its Affron® all-natural, non-GMO Spanish saffron extract (Crocus sativus L.) in the US market. The company's formulation boasts the lowest dosage threshold on the market — just 28mg per day — with proven bioavailability and rapid one-hour absorption.
Pharmactive will launch Affron at SupplySide West 2019 in Las Vegas, Booth #3943-B, on 17-18 October 2019.
Affron is standardized to Lepticrosalides®, a complex of bioactive compounds responsible for the beneficial and organoleptic attributes of Affron. The capabilities of this clean-label, synthetic-free, pure plant saffron extract is backed by several clinical studies. These compounds have been clinically shown to improve mood in healthy individuals, relieve stress and occasional sadness, support relaxation, and help enhance sleep. Affron also is the first saffron extract clinically studied on adolescents.
Free, in under 30 seconds
Join thousands of professionals reading Salaam Gateway — the Global Islamic Economy Gateway.
Already a member? Sign in
- 5 free articles every month
- Weekly Islamic-economy newsletter
- Save articles to read later
Press Release